From single- to multi-target drugs in cancer therapy: When aspecificity becomes an advantage

Annalisa Petrelli, Silvia Giordano

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'From single- to multi-target drugs in cancer therapy: When aspecificity becomes an advantage'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences